Although the terms "exercise" and "heart health" are practically synonymous, members of The International Society of Exercise and Immunology (ISEI) are accustomed to looking at the effects of exercise on a deeper level. More »

A potential way to halt the cartilage destruction that occurs with rheumatoid arthritis (RA) without suppressing the immune system has been identified by a new study supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). More »

It's that time of year when the clock has been turned back, days are shorter, and less time is spent outside in bright sunlight. It's also the time when vitamin D levels naturally decline. More »

Multidisciplinary management of fibromyalgia syndrome, including pharmacological and nonpharmacological interventions, is optimal. Exercise may improve patients’ symptoms and quality of life, but an exercise program may be challenging because of pain, stiffness, and fatigue. More »

Portable, bedside musculoskeletal ultrasonography (MSUS) equipment has placed the potential for advanced imaging in the hands of office-based clinicians. Assessment of synovial tissue is one of the main applications of MSUS in rheumatology. More »

Reactivation of latent tuberculosis infection (LTBI) has emerged as a problem in patients with rheumatoid arthritis (RA). Anti–tumor necrosis factor α therapy is strongly associated with reactivation of tuberculosis (TB) in patients with RA. More »

Idiopathic inflammatory myopathy is a term applied to a group of relatively rare diseases that present with the gradual onset of weakness of shoulder and pelvic girdle muscles. These diseases include polymyositis and dermatomyositis, as well as myositis associated with neoplastic disease, myositis... More »

The classic therapies for patients with systemic lupus erythematosus (SLE) often have significant toxicity. Corticosteroids provide a critical intervention when the disease is organ- or life-threatening, but the potential adverse effects are numerous. More »

Further evaluation of reasons for treatment nonadherence in patients with rheumatologic disease is key in the development of successful interventions. Patient education efforts alone are not sufficient to improve adherence; complex interventions are most effective. More »

The aging process is difficult, involving multisystem functional decline, and the pharmacokinetics of medications are altered in older persons, resulting in increased risks. Concerns are demonstrated in case reports. More »